MedPage Today on MSN
Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements
Results with Optilume consistent in clinical trials and real world, regardless of prostate ...
What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch well beyond its original purpose? That’s exactly the twist happening with a ...
Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...
A Shropshire hospital trust says patients with prostate cancer are benefitting from greater survival rates thanks to a ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...
An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...
Dr Amir Khan, who regularly provides health guidance across social media platforms and daytime television, works as an NHS GP ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results